These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12667667)

  • 1. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD
    J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.
    Kaufmann DE; Bailey PM; Sidney J; Wagner B; Norris PJ; Johnston MN; Cosimi LA; Addo MM; Lichterfeld M; Altfeld M; Frahm N; Brander C; Sette A; Walker BD; Rosenberg ES
    J Virol; 2004 May; 78(9):4463-77. PubMed ID: 15078927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
    Huang XL; Fan Z; Borowski L; Rinaldo CR
    Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.
    Mugaba S; Nakiboneka R; Nanyonjo M; Bugembe-Lule D; Kaddu I; Nanteza B; Tweyongyere R; Kaleebu P; Serwanga J
    Vaccine; 2014 Jun; 32(30):3787-95. PubMed ID: 24837770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
    Rutebemberwa A; Currier JR; Jagodzinski L; McCutchan F; Birx D; Marovich M; Cox JH
    AIDS; 2005 Jul; 19(11):1165-72. PubMed ID: 15990569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
    Hayes P; Fernandez N; Ochsenbauer C; Dalel J; Hare J; King D; Black L; Streatfield C; Kakarla V; Macharia G; Makinde J; Price M; Hunter E; ; Gilmour J
    PLoS One; 2021; 16(11):e0260118. PubMed ID: 34788349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes recognized by HIV-SF2 nef-specific CD4+ T-cell clones generated from HIV-1-uninfected donors.
    Wentworth PA; Bathurst I; Feucht PH; Erlich HA; Steimer KS
    Vaccine; 1994 Feb; 12(2):117-28. PubMed ID: 7511861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    Addo MM; Yu XG; Rathod A; Cohen D; Eldridge RL; Strick D; Johnston MN; Corcoran C; Wurcel AG; Fitzpatrick CA; Feeney ME; Rodriguez WR; Basgoz N; Draenert R; Stone DR; Brander C; Goulder PJ; Rosenberg ES; Altfeld M; Walker BD
    J Virol; 2003 Feb; 77(3):2081-92. PubMed ID: 12525643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses.
    Malnati MS; Heltai S; Cosma A; Reitmeir P; Allgayer S; Glashoff RH; Liebrich W; Vardas E; Imami N; Westrop S; Nozza S; Tambussi G; Buttò S; Fanales-Belasio E; Ensoli B; Ensoli F; Tripiciano A; Fortis C; Lusso P; Poli G; Erfle V; Holmes H
    J Immunol Methods; 2012 Jan; 375(1-2):46-56. PubMed ID: 21963950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.
    Malhotra U; Li F; Nolin J; Allison M; Zhao H; Mullins JI; Self S; McElrath MJ
    J Virol; 2007 May; 81(10):5225-37. PubMed ID: 17329342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa).
    Inwoley A; Recordon-Pinson P; Dupuis M; Gaston J; Genête M; Minga A; Letourneur F; Rouet F; Choppin J; Fleury H; Guillet JG; Andrieu M;
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):620-8. PubMed ID: 16060833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity.
    Lichterfeld M; Yu XG; Cohen D; Addo MM; Malenfant J; Perkins B; Pae E; Johnston MN; Strick D; Allen TM; Rosenberg ES; Korber B; Walker BD; Altfeld M
    AIDS; 2004 Jul; 18(10):1383-92. PubMed ID: 15199314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
    Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD
    J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.